Correlation Between ALRN Old and Evelo Biosciences
Can any of the company-specific risk be diversified away by investing in both ALRN Old and Evelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ALRN Old and Evelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ALRN Old and Evelo Biosciences, you can compare the effects of market volatilities on ALRN Old and Evelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ALRN Old with a short position of Evelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of ALRN Old and Evelo Biosciences.
Diversification Opportunities for ALRN Old and Evelo Biosciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ALRN and Evelo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ALRN Old and Evelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evelo Biosciences and ALRN Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ALRN Old are associated (or correlated) with Evelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evelo Biosciences has no effect on the direction of ALRN Old i.e., ALRN Old and Evelo Biosciences go up and down completely randomly.
Pair Corralation between ALRN Old and Evelo Biosciences
If you would invest (100.00) in Evelo Biosciences on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Evelo Biosciences or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
ALRN Old vs. Evelo Biosciences
Performance |
Timeline |
ALRN Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Evelo Biosciences |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
ALRN Old and Evelo Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ALRN Old and Evelo Biosciences
The main advantage of trading using opposite ALRN Old and Evelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ALRN Old position performs unexpectedly, Evelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evelo Biosciences will offset losses from the drop in Evelo Biosciences' long position.ALRN Old vs. Benitec Biopharma Ltd | ALRN Old vs. Artelo Biosciences | ALRN Old vs. Curis Inc | ALRN Old vs. ABVC Biopharma |
Evelo Biosciences vs. ABVC Biopharma | Evelo Biosciences vs. Surrozen | Evelo Biosciences vs. Processa Pharmaceuticals | Evelo Biosciences vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |